C12N 2502/1171
Haematopoietic stem cells
C12N2502/1171 (Haematopoietic stem cells) appears on 19 US grants and 60 published applications in this corpus.
Search patents in C12N- Granted patents
- 19
- Published applications
- 60
- Assignees
- 45
- Inventors
- 135
- Latest grant
- 10 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 3 |
| 2014 | 0 | 2 |
| 2015 | 1 | 2 |
| 2016 | 1 | 4 |
| 2017 | 3 | 3 |
| 2018 | 1 | 6 |
| 2019 | 0 | 3 |
| 2020 | 0 | 5 |
| 2021 | 1 | 3 |
| 2022 | 0 | 4 |
| 2023 | 2 | 4 |
| 2024 | 6 | 4 |
| 2025 | 2 | 7 |
| 2026 | 1 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Efficient and non-genetically modified iPSC-induced, industrialized single clone selection platform, and use10 Feb 2026US 12,545,898 B2Allife Medicine (Zhuhai) Limited
- Organoid compositions for the production of hematopoietic stem cells and derivatives thereof30 Sep 2025US 12,428,622 B2Children's Hospital Medical Center
- Osteoporosis model comprising calcium phosphate hydrogel composition and use thereof18 Mar 2025US 12,252,711 B2Medifab Co., Ltd.
- Method for producing extracellular vesicles comprising fetus-derived primal immunoglobulin26 Nov 2024US 12,150,962 B2Stemmedicare Co., Ltd.
- Endothelial cell factors and methods thereof19 Nov 2024US 12,146,165 B2Children's Medical Center Corporation
- Method for expanding immune cells27 Aug 2026US 2026/0250633 A1King's College London
- Stimulatory antigen particles, methods of production, and methods of use thereof20 Aug 2026US 2026/0242731 A1Genentech, Inc.
- Method for producing microglia-containing cerebral organoid13 Aug 2026US 2026/0234554 A1National Institute of Advanced Industrial Science and Technology
- Engineered endothelial cells expressing an ets transcription factor6 Aug 2026US 2026/0226421 A1Angiocrine Bioscience, Inc.
- Method for regulating degree of cell differentiation30 Jul 2026US 2026/0218131 A1National University Corporation Chiba University
Most cited
By later US patents
- Mesenchymal stromal cells and uses related thereto28US 8,962,321 B2Ocata Therapeutics, Inc. · 2015
- 3D in vitro bi-phasic cartilage-bone construct17US 9,856,458 B2Tissuse GmbH · 2018
- Method for developing natural killer cells from stem cells15US 9,260,696 B22016
- Skin equivalent comprising langerhans' cells9US 5,861,153 ASociete L' Oreal S.A. · 1999
- Megakaryocyte and platelet production from stem cells5US 9,574,178 B2New York Blood Center, Inc. · 2017